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The first three postnatal weeks in rodents are a time when sensory experience drives
the maturation of brain circuits, an important process that is not yet well understood.
Alterations in this critical period of experience-dependent circuit assembly and plasticity
contribute to several neurodevelopmental disorders, such as autism, epilepsy, and
schizophrenia. Therefore, techniques for recording network activity and tracing neuronal
connectivity over this time period are necessary for delineating circuit refinement in
typical development and how it deviates in disease. Calcium imaging with GCaMP6
and other genetically encoded indicators is rapidly becoming the preferred method for
recording network activity at the single-synapse and single-cell level in vivo, especially
in genetically identified neuronal populations. We describe a protocol for intracortical
injection of recombinant adeno-associated viruses in P1 neonatal mice and demonstrate
its use for longitudinal imaging of GCaMP6s in the same neurons over several weeks
to characterize the developmental desynchronization of cortical network activity. Our
approach is ideally suited for chronic in vivo two-photon calcium imaging of neuronal
activity from synapses to entire networks during the early postnatal period.
Keywords: neuronal activity, cortex, development, GCaMP, in vivo, rAAV, sparsification, two-photon
INTRODUCTION
The first three postnatal weeks in the mouse brain are of great interest to neuroscientists because
they coincide with critical periods of experience-dependent plasticity (Petersen, 2007) and a phase
of massive synaptogenesis (Micheva and Beaulieu, 1996; Holtmaat et al., 2009; Cruz-Martín et al.,
2012). In particular, the time period around postnatal day (P) 12 is one of drastic sensory transitions
as mice open their eyes, start whisking, and begin to actively explore their environment (Arakawa
and Erzurumlu, 2015; van der Bourg et al., 2016). These developmental processes are critically
important for understanding the causes of circuit dysfunction in a variety of developmental brain
disorders, such as autism, schizophrenia, epilepsy, and intellectual disability.
In the last two decades, we have witnessed a large number of technological innovations for
investigating neural circuits, from optogenetics and chemogenetics to rabies virus tracing and
tissue clearing methods for fluorescence microscopy. Two of the most notable advancements have
been the development of novel fluorescent calcium and voltage sensors, which allow researchers to
record neuronal activity with synaptic resolution (Grewe and Helmchen, 2009), and the enhanced
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microscopy capabilities for imaging the anatomy and function
of circuits across time in behaving animals (Wilt et al.,
2009). These developments, combined with the ability to use
a growing array of genetically encoded fluorescent molecules
(e.g., fluorescent proteins, channels, pumps, etc.) via mouse
genetics or viral transduction, now make it possible to trace
the inputs and outputs of individual neurons and to record
activity of specific neuronal cell populations in awake behaving
mice.
The development of the ultrasensitive fluorescent genetically
encoded calcium indicators (GECIs), especially GCaMP6 (Chen
et al., 2013), has dramatically improved the action potential
detection capability of two-photon calcium imaging. When
combined with Cre-Lox genetics, this approach is particularly
well suited for chronic recordings of neural activity in awake,
behaving animals at the single-cell level, and in identified
neuronal populations. The conventional approach for in vivo
two-photon calcium imaging with GECIs typically consists of
injecting a recombinant adeno-associated virus (rAAV) encoding
the sensor at the time of implanting a cranial window over the
desired cortical region. Imaging is typically performed 2–4 weeks
after surgery to allow for sufficient expression of the virus (Tian
et al., 2009; Chen et al., 2012, 2013; Zariwala et al., 2012).
Unfortunately, this delay between injection and optimal GCaMP
expression precludes calcium imaging experiments during the
early postnatal period in rodents.
Overcoming this technological limitation would allow
investigations to understand how experience shapes circuits
during the first postnatal weeks and other important
developmental milestones in the mouse brain. For example,
previous calcium imaging studies demonstrated that sensory
cortices undergo a rapid desynchronization of network activity
at postnatal day (P) 12 (Golshani et al., 2009; Rochefort et al.,
2009; Siegel et al., 2012). However, those studies employed
synthetic calcium indicators that could only be imaged acutely
for a few hours. Thus, the approach we outline here, which makes
it possible to express GECIs (or other proteins) during early
postnatal development and allows longitudinal imaging over
several days to weeks in the same animals (for example, before
and after P12), is a significant advance.
An alternative to the rAAV injection-based approach
presented here is to use transgenic mice that express GCaMP.
Unfortunately, in popular genetic mouse lines that drive
expression of GCaMP, the promoters come online after this
developmental period. For example, Thy1-GCaMP6 mice show
stable expression of GCaMP6 in multiple cortical regions across
months without apparent toxicity, but only after the third
postnatal week (Dana et al., 2014). Similarly, the Ai38 mouse
line expresses GCaMP3 when treated with tamoxifen at P7, but
showed very low expression at 4 weeks of age (Zariwala et al.,
2012). A different problem may occur when neuronal GCaMP6s
expression is driven too early (during embryonic development),
namely toxicity. For example, when we tried using in utero
electroporation at embryonic day 16 with plasmids encoding
GCaMP6s, we were able to use in vivo calcium imaging at around
P7-9 to visualize a handful of neurons in layer (L) 2/3 that
expressed GCaMP6s and showed synchronous activity. Just a few
days later at P10-11, we could no longer find any GCaMP6s-
expressing neurons, presumably due to neuronal cell death
(unpublished observations). We surmise that the expression of
GCaMP6s at early stages of neuronal differentiation or migration
is irreversibly toxic to neurons, and therefore, a transgenic mouse
line taking advantage of a promoter that would drive GECI
expression during embryonic development is likely to be toxic to
neurons.
Here, we describe a novel protocol for neonatal injection of
rAAV encoding GCaMP6s at P1, which enables in vivo two-
photon imaging of cortical neurons as early as P10. At P1, a
modified burr hole surgery was used to inject the rAAV encoding
GCaMP into the desired cortical area, and then at P8 or later,
a cranial window was implanted over the previously injected
area. Starting at day P11, repeated in vivo two-photon calcium
imaging of layer (L) 2/3 neurons was possible with adequate
GCaMP expression that persisted for weeks. We demonstrate
the major advantage of this approach to chronically image the
same population of neurons from P11 through young adulthood,
allowing us to characterize the developmental desynchronization
of cortical network activity and the evolution of sensory-evoked
network during this critical period. We believe this approach
will be valuable to the neuroscience community because the
same neonatal viral injection approach could be used to
express other genetically encoded calcium and voltage indicators,
chemogenetic or optogenetic actuators, rabies virus tracers, or a
variety of other fluorescent proteins, in different brain regions.
METHODS
Below, we provide detailed supply lists and step-by-step
instructions for virus injections in newborn mice, as well
as subsequent cranial windows. These protocols have been
optimized for targeting of GCaMP6s to L2/3 neurons of
barrel cortex for in vivo two-photon calcium imaging of
spontaneous and whisker-evoked activity starting in the
second postnatal week. Adjustments may be necessary
for targeting deeper layers or different brain regions. For
example, the choice of viral serotype and promoter will differ
depending on the cell population being targeted. For our
P1 injections, we used a rAAV1 with the synapsin promoter
(AAV1.Syn.GCaMP6s.WPRE.SV40) (Chen et al., 2013), diluted
to a working titer of 2E13 together with 1% filtered Fast Green
FCF dye (to visualize the spread of the injection). Additionally,
at E16 we used in vivo electroporation to introduce the
pCAG-tdTomato plasmid to layer (L) 2/3 precursor cortical
neurons.
Animals
All experiments followed the U.S. National Institutes of Health
guidelines for animal research, under an animal use protocol
(ARC #2007-035) approved by the Chancellor’s Animal Research
Committee and Office for Animal Research Oversight at the
University of California, Los Angeles. We used male and female
FVB.129P2 WT mice (JAX line 004828) and C57/BL6J mice
(HSD C57Bl/6NHsd) housed in a vivarium with a 12-h light-dark
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cycle. Experiments were performed during the light cycle.
Animals were weaned at P21-22 and afterward housed with up to
five mice of the same sex per cage. Before P21, pups were housed
with their dam.
Reagents
All reagents were obtained from Sigma unless otherwise
specified. All viral vectors were obtained from the University of
Pennsylvania Vector Core.
• O2 tank.
• Artificial Tears eye lubricant ophthalmic ointment (Henry
Schein, cat no. 048272).
• Sterile NaCl (Addipak, Teleflex cat no. 200-59).
• AAV vector encoding GCaMP (U. Penn virus core), diluted
to 2e13 concentration with 1% Fast Green.
• 70% ethanol (Sigma-Aldrich, cat no. R3154-1GA).
• Betadine (Purdue Products, NDC 67618-155-16).
• Sterile Gelfoam (absorbable gelatin sponge) (Ethicon,
Devine Medical cat no. MED-ETH1975).
• Cyanoacrylate glue (Krazy Glue, Office Depot, cat no.
366490).
• Ortho-Jet dental acrylic powder and liquid (Lang Dental,
cat nos. B1330 and 1306).
Drugs
• Lidocaine HCl 2% + epinephrine 1:200,000 (Fresenius-
Kabl, cat no. 480927).
• Dexamethasone 2 mg/ml (Henry Schein, cat no. 002459).
• Carprofen (Rimadyl, 50 mg/ml, Zoetis).
• Isoflurane (Henry Schein, cat no. 029405). Note:
Procedures using isoflurane should be conducted in
well-ventilated areas, and should follow relevant animal
care guidelines.
Equipment
• Glass capillary puller (Narashige, model PC-10).
• Glass capillaries, O.D. 1.5 mm, I.D. 0.86 mm (Sutter
Instruments, cat no. BF150-86-10).
• Picospritzer injection device (Parker Hannifin, model
Picospritzer III).
• Glass bead sterilizer (Fine Science Tools, cat no. 18000-45).
• Water recirculating heating blanket (Stryker, cat no. 8002-
062-012) and pump (Gaymar, cat no. 07999-000).
• Rodent trimmer (Wahl, cat no. 9962-717).
• Dissecting microscope (Zeiss, model Stemi 2000).
• Gooseneck light source (Dolan-Jenner MI-150, Edmund
Optics cat no. 59-236).
• Stereotaxic frame and mouse adaptor (Kopf, cat nos. 900
and 926) (Figure 1A).
• Anesthetic vaporizer (Surgivet Classic T3) with airflow
meter (Porter, cat no. GL-616).
• Induction chamber (VetEquip, cat no. 941443).
• Pneumatic dental drill (Midwest Tradition, Henry Schein,
cat no. 7726063) with FG 1/4 carbide burr drill bits (Henry
Schein, cat no. 100-7205).
• Dumont tweezers #4 and #5, straight dissecting scissors,
10 cm (World Precision Instruments cat nos. 500231,
14098, 14393).
• Small petri dish (35-mm diameter, Fisher, cat no.
FB0875711YZ).
• Sterile cotton swabs (Henry Schein, cat no. 100-9175).
• Glass coverslips, 5 mm (Electron Microscopy Sciences, cat
no. 72195-05).
• Needle tips, 18-gauge (BD, cat no. 305195).
• Titanium head bars (custom design: 0.125 × 0.375 × 0.05
inches).
• 2-photon microscope (custom built) (Cruz-Martín et al.,
2010).
• Tunable Ti:Sapphire laser (Chameleon Ultra II, Coherent).
• Objectives, 4× (0.8 N/A) and 20× (0.95 N/A) water
immersion (Olympus, UPLFLN 4×, XLUMPLFLN 20×).
• ScanImage (Pologruto et al., 2003).
Set-Up
• Pipette preparation for injection: pull a custom
micropipette from a 1.5 mm outer diameter/0.86 mm
inner diameter glass capillary tube so that the length of
the tapered tip is approximately 8 mm. Break pipette tip
slightly by gently touching the tip to the side of sterilized
forceps. The o.d. of the tip should be 12.5–25 µm. If the tip
is too wide, the viral vector may reflux around the needle
during the injection.
• Gelfoam preparation: use sterilized scissors to cut small
pieces of Gelfoam, approximately 1 mm × 1 mm. Soak
them in a small petri dish filled with sterile saline.
• Surgical instruments: sterilize instruments in a glass bead
sterilizer and spray with ethanol before use.
• Heating blanket: turn on the water recirculating heating
blanket 15 min before start of each surgical procedure.
Step-By-Step Procedures
rAAV Injection at P1 (Timing 15–20 min)
1) Preoperative care: Administer Carprofen (5 mg/kg BW, s.c.)
to the mouse. Note: we do not use dexamethasone for the
virus injection in newborn pups.
2) Anesthetize the mouse with 5% isoflurane for induction,
followed by 1.5–2% isoflurane for maintenance (vol/vol, via
nosecone).
3) Use blunt ear bars to position the mouse on the
stereotax so that the desired injection area is as flat as
possible (Figure 1B). Ensure that the mouse pup remains
warm (on the heating pad) throughout the procedure,
and monitor breathing carefully, including tail and toe
pinches. The ear bars should prevent movement of the
pup during subsequent manipulations, without applying
excessive pressure to its soft skull. Ensure that the heating
blanket is functioning correctly. Note: newborn pups can
stop breathing suddenly, making close monitoring under
anesthesia crucial.
4) Sterilize operating field using three alternating wipes each
of betadine and 70% alcohol.
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FIGURE 1 | P1 injection setup and procedure. (A) Dissecting microscope with goose-neck illumination. (B) Positioning of P1 pup with blunt ear bars, isoflurane
delivery and exhaust tubes, pneumatic dental drill, forceps, iridectomy scissors, fine forceps, sterile saline vial, sterile cotton swab, and petri dish with Gelfoam
sponges soaking in sterile saline. (C). Creating a 3–4 mm triangular skin flap over the desired injection area. (D) Folding back the skin flap and covering with wet
Gelfoam to prevent the skin flap from drying out. (E) Light drilling of exposed skull to crack the bone slightly. (F) Injection of rAAV-GCaMP with glass micropipette.
(G) Sealing of injection site with VetBond. (H) Sealing of skin flap with VetBond.
5) Using the scissors, make one snip to create a 3–4 mm
triangular skin flap over the desired injection area
(Figure 1C and Supplementary Figure S1A). Fold back
the skin flap and cover it with a piece of saline-soaked
Gelfoam to prevent the skin from drying (Figure 1D and
Supplementary Figures S1B,C).
6) Immediately apply a small drop of lidocaine/epinephrine
onto the exposed skull. After 30 s, dry the surface of the
skull with sterile cotton swab or dry Gelfoam.
7) Using the pneumatic dental drill, gently stroke the drill
bit tip onto the skull surface to clear the periosteum. Use
Gelfoam soaked in saline to clean the area of bone dust, then
let the area dry. Note: do not push hard on the skull or the
drillbit might pierce the bone and damage the dura/brain.
8) Once the exposed skull is clear of periosteum and dry,
apply repeated light touches of the drill bit tip at the
desired injection site until the bone has cracked enough to
permit insertion of the glass micropipette (Figure 1E and
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Supplementary Figure S1D). Clean up any bleeding with
moist Gelfoam. Ideally, there should be no bleeding. Note:
if a large hole in the skull is created during the drilling, it
will likely delay healing and result in a larger scar, which
will make the later cranial window surgery less successful.
The animal will likely not be suitable for imaging.
9) Load glass micropipette with approximately 200 nl of
rAAV-GCaMP (working titer 2e13) with FastGreen and
position for injection at a 45◦ angle to the skull surface.
10) Lower pipette until its tip has pierced through the
cracked bone and into superficial cortex (Figure 1F
and Supplementary Figure S1E). Inject rAAV using the
Picospritzer using approximately 30 puffs of 3–5 ms
durations at 40 PSI. Leave the pipette in place for 15 s
and then withdraw pipette. Note: if fluid comes out of the
skull surface around the pipette after withdrawal, it is an
indication that its tip was not sufficiently small. The animal
will likely not be suitable for imaging.
11) Using a needle tip (e.g., 18-gauge), apply a very small drop
of VetBond to the injection site (just enough to seal the
cracked area but not enough to reach the skin edges) and
let dry completely (Figure 1G and Supplementary Figure
S1F).
12) Replace the skin flap and seal the skin edges with a small
amount of VetBond (Figure 1G and Supplementary Figures
S1G,H).
13) Allow VetBond to dry before placing mouse in warm
recovery cage. After the mouse completely recovers from
anesthesia, return it to the litter. Carefully monitor the
dam to ensure reintegration of the post-operative pup(s).
Minimize rearrangements of the litter in the cage to
minimize stress on the dam and reduce the possibility of
cannibalism. Placing a small cardboard shed in the cage can
also reduce stress for the dam.
Cranial Window Procedure at P8–P10 (Timing
45 min–1 h) (Modified Slightly From Cruz-Martín
et al., 2010; Holtmaat et al., 2012)
1) Anesthetize the mouse with 5% isoflurane for induction,
followed by 1.5–2% isoflurane for maintenance. Monitor
anesthesia level throughout surgery by watching breathing,
as well as using tail and toe pinches, and ensure that heating
blanket is functioning correctly.
2) Use rodent trimmer to shave from the neck to the eyes,
being careful not to trim any whiskers.
3) Use blunt ear bars to position mouse on stereotaxic frame,
with anesthesia nose cone. The ear bars must be secured
with just enough pressure such that the mouse’s head does
not shift during surgery. The skull is still soft at P8-10
and care must be taken not to excessively squeeze the skull
between the bars, as this will affect respiratory rate.
4) Administer Carprofen (5 mg/kg BW, s.c.) and
dexamethasone (0.2 mg/kg BW, s.c.).
5) The original injection site should be apparent as a well-
healed triangular scar on the skin, not raised or inflamed.
If a large plug of granulation tissue is present at the
original injection site and the skin is attached to the skull
underneath, there is likely an excessive amount of scarring
that will preclude a successful window surgery. The animal
will likely not be suitable for imaging.
6) Sterilize the skin with three alternating wipes each of
betadine and 70% alcohol.
7) Using the scissors, remove the skin on top of the skull, as
well as the periosteum. Apply lidocaine/epinephrine to skin
edges. After 30 s, dry the skull surface using cotton swabs.
8) Apply a small amount of cyanoacrylate glue to the skin
edges, but do not apply glue over the bony sutures.
9) Use a pneumatic dental drill to very lightly carve
a circular craniotomy, 3 mm in diameter. Apply
lidocaine/epinephrine, let sit for 30 s, then dry skull.
The skull at P8-10 is still very soft and the bone near the
original burr hole may be particularly brittle. Drilling
should proceed with minimal pressure to reduce the chance
of sudden penetration and excessive bleeding.
10) Continue to gently drill along a circular groove until
bone has been cracked all around the perimeter of the
craniotomy. Clean up any bleeding on the bone with
Gelfoam. The drilling can stop when the skull at the center
of the craniotomy gives way as one pushes gently on it with
the dental drill tip.
11) Soak the entire drilled area with saline using Gelfoam for
at least 1 min. Then use fine-tipped forceps to gently lift
the skull flap. Use Gelfoam to wipe away any residual scar
tissue from the original burr hole and injection. Note: apply
Gelfoam to stop any minor bleeding on the surface of the
dura. Minimal bleeding at the edge of the window, if readily
stopped with Gelfoam, will not impede imaging that same
day. However, significant bleeding, bruising, or damage of
the dura in the center of the window will preclude same-
day imaging and, if severe, may also preclude subsequent
imaging.
12) After the skull is removed use copious saline to irrigate the
surface of the dura to remove bone dust. Note: if some bone
dust remains, this will increase the chances of subsequent
bone re-growth under the glass window.
13) While the dura is moist with saline, gently position a 3 mm
glass coverslip over the craniotomy.
14) Hold the coverslip by applying gentle pressure on the center
of the glass with the wooden end of a cotton swab (or
with forceps) so that the glass is firmly resting against
the bone edges. With the other hand, apply small drops
of cyanoacrylate around the edges of the coverslip at two
or three points, then drag it around the perimeter of the
window. Cyanoacrylate should not seep under the glass and
onto the dura. Let cyanoacrylate dry completely. Note: if
some glue seeps under the glass, the animal will likely not
be suitable for imaging.
15) Mix dental acrylic and apply over the entire skull surface
around the window, sealing the edges of the coverslip.
Use the same acrylic to secure a custom titanium headbar
to an area of the head cap that will not interfere with
the positioning of the microscope objective during in vivo
imaging. The plane of the headbar should be parallel to that
of the coverslip. Also use dental acrylic to make a small well
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around the window to hold water for the 20× immersion
objective.
16) Allow the dental acrylic to cure for 5–10 min, and then
move the mouse to a warm recovery cage. When the mouse
has recovered from anesthesia completely, return to the
litter. Monitor the dam closely to ensure the pups are
safely reintegrated. Placing a cardboard shed in the cage can
improve the dam’s caretaking of pups.
17) The mouse can be imaged later the same day, as long as the
dental acrylic on the head cap and head bar is fully cured.
Please also refer to Supplementary Table S1 for tips for
improving injection efficacy while minimizing tissue damage and
overall morbidity in newborn mice. Minimizing tissue damage
and the resulting inflammation is key for successful cranial
window implantation within 10 days of viral injection and to
ensure subsequent window clarity (Figure 2).
Electrophysiology
The brains were quickly removed and transferred to ice-cold
artificial CSF (ACSF) containing (in mM): 119 NaCl, 2.5 KCl,
1.3 MgSO4, 1 NaH2PO4, 2.5 CaCl2, 26.2 NaHCO3, and 10
dextrose, bubbled with oxygenated 95% O2/5% CO2 to a final
pH of 7.4. Acute coronal brain slices (300 mm) through the
barrel cortex were cut on a vibratome (Leica VT1000S). The
acute slices were incubated at 37◦C in oxygenated ACSF for
1 h and then placed on a chamber maintained at 35–37◦C on
the stage of an upright Olympus BX51 microscope. Slices were
submerged in ACSF, perfused at a rate of 2–4 ml/min, and
bubbled with 95% O2/5% CO2. L2/3 pyramidal neurons were
identified using differential interference contrast optics with a
60× 0.8 NA water immersion objective (Olympus). Cells were
patched for 15–30 min and recordings were performed using
whole-cell patch-clamp technique in current clamp configuration
(Axon Instruments, Multiclamp 700B). Series resistances were
manually compensated for standard patch pipettes (6–9 M
tip resistance) pulled on a Brown/Flaming microelectrode puller
(Sutter Instruments, model P-97). Pipettes were filled with an
intracellular solution containing (in mM): 130 K-gluconate,
5 KCl, 2 MgCl2, 10 HEPES, 4 Mg-ATP, 0.3 Na-GTP, 10
phosphocreatine, and 2 Alexa-488, adjusted to a final pH of
7.3. The ACSF solution in which slices were maintained was
consistent between recordings with the exception of the [KCl],
FIGURE 2 | Cranial windows implanted at P10 remain optically transparent for
weeks. Photographs of the cranial window at P11, P15, and P30 for a
representative mouse injected with rAAV-GCaMP6s at P1.
which ranged from 1.25 to 5 mM. The input resistance (Rm) or
membrane potential (Vm) did not change more than 10% during
the course of recording for each cell. All electrophysiological
recordings were sampled at 10 kHz, digitized with custom
written MATLAB software controlling an A–D board (National
Instruments, PCI-6723), and saved for off-line analysis. All
analyses were performed using custom-written software in
MATLAB.
In Utero Electroporation
In utero electroporation was performed as previously reported
(Cruz-Martín et al., 2010, 2012). In short, pregnant female mice
at gestation day E16 were anesthetized with isoflurane (5%
induction, 1.5–2% maintenance vol/vol). A medial incision along
the abdomen was made exposing the abdominal cavity. The
uterine horns were gently exposed and each embryo was pressure
injected with a plasmid encoding pCAG-tdTomato (500 ng/µl)
in the left lateral ventricle with a Picospritzer. A set of three
square pulses (50 ms duration, 35 V with 500 ms between
each pulse) was administered to each embryo via a custom-
built electroporator with the positive electrode paddle placed
over the left somatosensory cortex. Throughout the procedure,
the embryos were frequently irrigated with warm saline (37◦C).
The embryos were placed back inside the mother and the dam’s
abdominal wall was sutured with absorbable sutures (muscle) and
nylon sutures (skin).
Histology
A 16-day-old mouse that underwent P1 injection was perfused
intracardially with ice-cold 4% paraformaldehyde in 0.1 M
phosphate buffer. The brain was then harvested and post-
fixed overnight with 4% paraformaldehyde in 0.1 M phosphate
buffer at 4◦C. The brain was sliced in 100 µm-thick sections
on a vibratome. Sections were mounted onto coverslips with
Vectashield with DAPI (Vector Laboratories). Sections were
imaged with an Olympus IX71, 10× obj with a N/A = 0.3.
Optical Intrinsic Signal (OIS) Imaging
After the cranial window placement, OIS imaging was used at
P16 to obtain whisker-responsive maps and confirm appropriate
targeting of rAAV injection to the barrel cortex. Following
a protocol previously described (Johnston et al., 2013), the
contralateral whisker bundle was attached using bone wax to a
glass needle coupled to a piezo-actuator (Physik Instrumente).
Each whisker stimulation trial consisted of a 100 Hz sawtooth
stimulation lasting 1.5 s. In order to delineate the cortical
representation of whisker stimulation, the response signal was
divided by the averaged baseline signal, summed for all trials, then
thresholded at 50% of maximum response. OIS signal intensities
were used solely for localization during calcium imaging and were
not compared between animals.
In Vivo Two-Photon Calcium Imaging in
Head-Restrained Mice
Calcium imaging was performed on a custom-built two-photon
microscope, with a Chameleon Ultra II Ti:Sapphire laser
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(Coherent), a 20× objective (0.95 NA, Olympus), and ScanImage
software (Pologruto et al., 2003). Mice were lightly sedated with
chlorprothixene (2 mg/kg, i.p.) and isoflurane (0–0.5%), and kept
at 37◦C with an electric heating blanket (Harvard Apparatus).
Isoflurane was manually adjusted to maintain a breathing rate
ranging from 100 to 150 breaths/min for P11-16 mice. Both
spontaneous activity and whisker-evoked barrel cortex activity
were recorded in the same mice at three postnatal ages, P11,
P15, and P30. Whisker stimulation was delivered by bundling
the contralateral whiskers (typically all macrovibrissae of at least
∼1 cm in length) to a glass needle coupled to a piezo-actuator
with soft bone wax. Whiskers were stimulated for 1 s at 10 Hz
with 10 s interstimulus intervals (i.s.i.), for a total of 10 stimuli
(for network imaging) or with an i.s.i. of 5 s (for spine imaging).
Whole-field images were acquired at 7.8 Hz (1024 × 128 pixels
down-sampled to 256 × 128 pixels) for (network imaging) and
0.98 Hz for (spine imaging) (512 × 512 pixels). Spontaneous
activity recordings lasted 60 s.
Data Analysis for Calcium Imaging
Calcium-imaging data were analyzed using custom-written
MATLAB routines, as described (He et al., 2017). All relevant data
and MATLAB code are available upon request to the authors. X-Y
drift in the movies was corrected using a cross-correlation-based,
non-rigid alignment algorithm (Mineault et al., 2016). The choice
of registration algorithm did not affect the data analysis, since the
fluorescence data for each neuron was always normalized to its
own baseline. A semi-automated algorithm (Chen et al., 2013)
was used to select regions of interest, each representing a single-
cell body, and extract the fluorescence signal (1F/F) for each
neuron. A “modified Z-score” Z_F time series for each neuron
was calculated as
Z_F(t) = F(t) − mean (quietest period)
std (quietest period)
where the quietest period is the 10 s period with the lowest
variation (SD) in 1F/F. All subsequent analyses were performed
using the Z_F(t) time series.
For analysis of aggregate activity within a particular time
range, the mean of Z_F(t) within that time range was calculated
for each ROI, and for each animal imaged, these means were
compared across P11, P15, and P30. Only cells that had at
least one calcium transient during the recording at all three
postnatal ages were analyzed. To define whether an individual
cell was “whisker-responsive,” i.e., showed time-locked responses
to whisker stimulations, we used a probabilistic bootstrapping
method, wherein we compared correlations between the stimulus
time-course vs. the Z_F time series with correlations between
the stimulus time-course and 1,000 scrambles of all calcium
activity epochs in Z_F(t) (epoch = consecutive frames wherein
Z_F(t) ≥ 3), as was previously described (He et al., 2017).
Statistical Analyses
Graphs in Figure 6 show data from neurons that were active
across all time points P11, P15, and P30. For each ROI the Z_F(t)
averages were calculated. To calculate statistical significance,
Friedman’s two-way analysis of variance (ANOVA) by ranks for
related samples was used with post-hoc pairwise comparisons
corrected with Bonferroni adjustments. Pearson’s correlations
were determined using custom MATLAB code and Friedman’s
two-way ANOVAs by ranks were determined using SPSS 24
software (IBM). Graphs in Figure 4 show all data points, as well
as group medians. Based on the group sizes of n = 6, we used
unpaired rank-based comparisons with bootstrapping (10,000
resamples), implemented using custom-written R code. Two-
sided p-values were calculated, and the threshold for significance
was set at p< 0.05.
RESULTS
We performed intracranial rAAV-Syn-GCaMP6s injections in
anesthetized mouse pups at P1 through a small burr hole over
primary somatosensory cortex, as described in the Materials and
Methods (Figure 1 and Supplementary Figure S1). When we used
fluorescence microscopy of fixed tissue slices at P16 and later
to survey the extent of GCaMP6s expression, we saw that there
was no evidence of trauma from the injection, nor was there any
obvious cortical pathology. In fixed brain tissue at P16 we could
identify expression of GCaMP6s in both L2/3 and L5 neurons
(but not in L4) throughout nearly the entire injected hemisphere
(Figure 3).
To confirm that neonatal GCaMP6 expression does not have
cytotoxic effects on neurons, we used patch-clamp recordings in
acute brain slices from two P16-17 pups that had been injected at
P1, and two uninjected littermates at the same age, as previously
described (Goel and Buonomano, 2016). We did not find
statistically significant differences in either the input resistance
(Rm) or the resting membrane potential (Vm) between GCaMP-
expressing cells and cells from uninjected controls (p = 0.51 and
p = 0.12, respectively; unpaired rank-based comparisons with
bootstrapping; n = 6 cells per group) (Figure 4), suggesting that
neonatal GCaMP expression does not have adverse effects on the
neurons. We did not observe significant loss of neurons between
FIGURE 3 | Expression of GCaMP6s in L2/3 and L5 after P1 injection.
(A) Coronal view of a section through the brain of a P16 mouse that was
injected with rAAV-Syn_GCaMP6s at P1. Note the spread of the expression
across the hemisphere and the abundant expression in L2/3 and L5, but not
L4. Scale bar = 500 µm. (B) Higher magnification image of GCaMP6s
expression in L2/3 and L5. Scale bar = 100 µm.
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FIGURE 4 | L2/3 neurons expressing GCaMP6s since P1 show normal
electrophysiology. (A) Input resistance (Rm) during whole-cell recordings of
L2/3 neurons from P16-17 mice injected with AAV-GCaMP6s at P1, or from
uninjected littermates (n = 2 mice each). Each circle represents data for one
cell, bars represent group medians, and p-values are from unpaired
rank-based two-group comparison with 10,000 resamples. (B) Resting
membrane potential (Vm) for the same comparison.
FIGURE 5 | td-Tomato expression to help identify the same GCaMP6s field of
view for calcium imaging. Representative fields of view of GCaMP6s and
td-Tomato-expressing neurons in barrel cortex of a mouse at three different
postnatal ages. This animal was electroporated in utero at E16 with a plasmid
encoding the red fluorescent protein td-Tomato and then was injected with
rAAV-GCaMP6s at P1. Expression of td-Tomato allowed us to identify the
same field of view throughout postnatal development because of stable
expression of clusters of neurons in the red channel (yellow dotted ellipses).
P11 and P30 in the mice we imaged. However, with ongoing
expression, we did observe a slight increase in the proportion
of “filled-in” cells in areas of peak expression, closest to the
original injection site. The percentage of all segmented soma
ROIs that appeared “filled-in” was 2% at P11, 7% at P15 and
7% at P30. We did appreciate a slight decrease in the fraction of
cells that demonstrated spontaneous activity, from 96% at P11 to
86% at P30.
To assess the suitability of neonatal viral injections for
investigating cortical circuits in early postnatal mice, we used
in vivo two-photon calcium imaging to record neuronal activity.
We specifically chose to perform an experiment that could
not have been possible without neonatal viral injections. We
and others have previously demonstrated that cortical network
activity undergoes a major network transformation at around
the second postnatal week, such that neuronal activity becomes
desynchronized (Golshani et al., 2009; Rochefort et al., 2009;
Siegel et al., 2012; Gonçalves et al., 2013). However, those studies
had recorded from different mice at different ages, so to this
date, it had not been possible to record form an identified
ensemble of neurons across time in a single animal. In order
to achieve this, we injected three mice at P1 with rAAV-Syn-
GCaMP6s.
Next, we permanently implanted glass-covered cranial
windows at P8-10, following protocols we have previously
established (Portera-Cailliau et al., 2005; Cruz-Martín et al.,
2010, 2012). There are, however, important considerations
when performing cranial window implants in mice previously
injected with rAAV at P1. For example, the P1 injection
can cause scarring in the injected area, which can make the
subsequent cranial window surgery more difficult and reduce
experimental efficiency. Scarring can be minimized by the
following considerations during the virus injection: (1) a rapid
surgical procedure with carefully calibrated anesthesia levels;
(2) gentle burr hole drilling (with the drill at a 45◦ angle
to the skull) that produces only a small crack in the skull
through which the glass pipette can be smoothly inserted,
without any visible signs of bleeding; (3) careful cleaning of
the periosteum prior to and after the injection to prevent
granulation tissue from forming at the site of injection, which
would otherwise soften the bone and make the cranial window
surgery more difficult; (4) careful application of the minimal
amount of VetBond to seal the drilled area and, separately,
the skin edges so that the skull and skin are not glued to
each other. Injections done at P2 or later will drastically
increase the chances of scarring. If there is scarring, then
the subsequent cranial window surgery may be much less
successful, reducing the experimental success rate. Following the
recommendations above, as well as the steps in the Materials
and Methods and the troubleshooting recommendations
(Supplementary Table S1), can help ensure that windows remain
clear for repeated imaging in previously injected neonatal mice
(Figure 2).
In order to more easily identify the same ensemble of
neurons over time, we used in utero electroporation to express
td-Tomato in L2/3 neurons in S1 cortex (Figures 5 and 6).
We performed in vivo calcium imaging of spontaneous network
activity in slightly sedated, head-restrained mice from P11 to
P30. At P11, L2/3 neurons in barrel cortex exhibit large but
infrequent spontaneous calcium transients that are synchronous
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FIGURE 6 | Developmental desynchronization of network activity in barrel cortex. (A) Example field of view for a two-photon imaging recording of
GCaMP6s-expressing layer (L) 2/3 neurons in barrel cortex from a representative in vivo experiment at P11, P15, and P30 (xyt SD projection of 1,040 consecutive
frames at 7.8 Hz). Example cells that could be identified at all three ages are labeled by yellow circles and numbers. For some of these cells, the corresponding
fluorescence calcium traces are shown in panels (B,E). (B) Spontaneous activity 1F/F calcium traces of eight individual L2/3 neurons from the same field of view as
in (A), at P11, P15, and P30. (C) Correlation matrices displaying the correlation coefficients between the deconvolved calcium traces of all possible pairs of cells
(n = 24) shown imaged in (A). (D) Pair-wise correlation coefficients across developmental ages for three different mice. The bold line indicates data from the example
recording shown in panels (A–C,E). ∗∗p < 10−3, ∗∗∗p < 10−5. (E) Whisker-evoked activity 1F/F calcium traces of eight individual L2/3 neurons from the same field
of view as in panel (A), at P11, P15, and P30. Vertical gray bars represent epochs of whisker deflection (10 Hz, 1 s duration, 10 s i.s.i.). (F) Magnitude of
spontaneous activity (as determined by average Z scores of calcium traces). In panels (F,G), the bold line indicates data from the example recording shown in panels
(A–C,E). ∗∗∗p < 10−5. (G) Magnitude of whisker-evoked activity (average Z scores). ∗∗∗p < 10−5. (H) Percentage of all L2/3 neurons imaged whose activity was
time-locked to epochs of whisker stimulation (see Materials and Methods) for all three mice (n = 296, 401, and 248 neurons respectively).
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FIGURE 7 | Loss of synchronous spontaneous activity of L2/3 neurons in developing barrel cortex coincides with their ability to respond to whisker stimuli between
P11 and P15. (A) Overlay of fluorescent traces of spontaneous activity of the neurons in Figure 6A field of view. Different color traces are from different neurons
(n = 24). (B) Neuronal activity is time-locked to whisker stimulation at P15, but not at P11. Traces were aligned to whisker stimulus and averaged over all 10 stimuli
(bold traces).
across the bulk of the neurons (Figure 6B). These giant network
events have been previously described in acute cortical slices
(Garaschuk et al., 2000; Allene et al., 2008) and in vivo (Golshani
et al., 2009; Rochefort et al., 2009). In contrast, by P15, activity
has become largely desynchronized, and this sparse firing of
neurons prevailed at P30. To quantify the magnitude of this
change in network behavior, we computed pairwise Pearson’s
correlation coefficients for all possible pairs of neurons that
had been imaged at all three ages from their deconvolved
calcium traces (Figures 6C,D). The mean correlation coefficient
of all cell pairs decreased significantly from 0.24 ± 0.01
at P11 to 0.06 ± 0.01 at P15 and 0.02 ± 0.01 at P30
(Figure 6D).
We also recorded whisker-evoked activity at these same
postnatal ages and observed clear whisker-evoked activity as early
as P15 (Figure 6E). At P11, bursts of activity were so broad
(sometimes lasting several seconds) that it was not possible to
determine whether neurons were indeed responding to tactile
stimulation. We also calculated the proportion of L2/3 neurons
that responded to whisker stimulation in a time-locked fashion,
as previously described (He et al., 2017), and found that the
transition from a highly synchronous to desynchronized pattern
of L2/3 activity between P11 and P15 coincides with the increase
in responsiveness to whisker stimuli (Figure 7). We also found
that the fraction of L2/3 neurons with activity that is time-locked
to the epochs of whisker stimulation appears to decrease from
P15 to P30 (Figure 6H).
The neonatal viral injection approach also allowed us to record
GCaMP6 signals in individual dendrites and dendritic spines
of L2/3 neurons in early postnatal mice. We find that even by
P15, individual dendritic spines display whisker-evoked activity
(Figure 8). Interestingly, among neighboring spines within the
same dendritic shaft some exhibited whisker signals, while others
did not. Hence, this approach will be useful to unravel the role of
individual dendritic spines in local circuit computations during
early postnatal development.
DISCUSSION
We have presented a detailed description for a relatively
straightforward protocol to express desired proteins in the
neonatal mouse brain. Our postnatal injection protocol is very
versatile, as it allows for successful targeting of specific cortical
areas. For example, we recently used this neonatal virus injection
approach to express GCaMP6s in barrel cortex of wild-type and
Fmr1 knockout mice (a model of Fragile X Syndrome), which
allowed us to record the spontaneous and whisker-evoked activity
of L2/3 neurons at P14-16 (He et al., 2017). This study revealed a
novel cortical circuit defect in Fragile X mice, namely, the absence
of adaptation in the activity of neurons to repeated whisker
stimulation.
Our protocol does have some limitations. First, although
we achieve GCaMP6s expression in L2/3 and L5, using the
present rAAV1 and synaptophysin promoter, we failed to target
expression to L4 neurons. Second, despite the fact that we could
follow the same neurons from P11 to P30, it is admittedly
difficult (if not impossible) to follow the entire population of
neurons across these ages. For example, blood vessel growth
within the developing cortex (which can obscure fluorescence
from portions of the original field of view), or shifts in cell body
position in the z-axis as the brain expands, prevented us from
tracking the same cohort of cells. Third, there are considerable
technical hurdles associated with performing successful, long-
lasting cranial windows at P8-10, at the same site that was
injected at P1. Scarring/healing around the injection site makes
the skull more brittle, increasing the difficulty of the subsequent
craniotomy. Additionally, whether the P1 injection was optimal
or suboptimal (e.g., with excessive scarring) is not clear until
the time of window placement. In our troubleshooting table
(Supplementary Table S1), we further describe these technical
issues.
There is some precedent for the use of neonatal injection
of AAV vectors in neuroscience. A P0-1 injection of an AAV
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FIGURE 8 | Imaging of GCaMP6s signals in dendritic spines of L2/3 neurons in barrel cortex at P15. (A) Field of view of apical dendrites from a representative
experiment in a P15 mouse injected at P1 with rAAV-GCaMP6s (xyt st-dev projection of 80 slices over ∼80 s). Time-lapse images of calcium recording of spines 1
and 2 (circles) and dendrite 4 (boxed region) are shown in (B,C). (B) Time lapse imaging sequence of dendritic spines 1 and 2 shown in (A) over five consecutive
whisker stimulations (vertical gray bars). Each image is one frame (0.98 Hz image acquisition). Asterisks for each spine in (B) correspond to those in panel (D).
(C) Time lapse imaging sequence of the dendrite shown in (A) (box 4) over several seconds and a whisker stimulation (gray bar). Each image is one frame (0.98 Hz
image acquisition). The asterisk above the time frame at 36 s corresponds to the asterisk in panel (D). (D) 1F/F traces for the calcium fluorescence signals for the
dendritic spine and dendrite shaft regions of interest 1–4 shown in (A), over 10 sequential whisker stimulations.
vector encoding Chronos-GFP into the rat visual cortex
was used to enable optogenetic stimulation of visual cortex
neurons with concurrent recording of thalamic activity
(Murata and Colonnese, 2016). In mice, a P0 intraventricular
injection of an AAV vector encoding YFP or Cre-tdTomato was
shown to produce strong expression as early as P2, with levels
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of expression comparable to adulthood at P7 (Kim et al., 2013).
However, the authors demonstrated the use of this approach only
for structural imaging in fixed tissue, whereas we demonstrate
benefits of longitudinal calcium imaging of network activity
in living mice. Another paper used a similar approach to
inject a rAAV1 encoding for GCaMP6f at P0-3 and performed
in vivo two-photon calcium imaging of odor-evoked responses
in olfactory bulb tuft cells (Cheetham et al., 2015). However, the
earliest cranial window implantations and in vivo imaging in that
study were done at P25, and only at a single imaging time point.
The same could have probably been accomplished with rAAV
injection at P10-15 at the time of the cranial window surgery.
We demonstrate in vivo imaging of neocortical neurons starting
2 weeks earlier, at P11, and with repeated imaging of the same
neuronal ensembles over a period of >2 weeks.
Previous studies have also used in utero electroporation in
mice to transfect L2/3 and L5 precursors with channelrhodopsin
and tDimer2, focusing on the prefrontal cortex and hippocampus
(Bitzenhofer et al., 2017a,b), enabling manipulation of neuronal
activity in the prefrontal cortex or hippocampus, as well as in vivo
electrophysiology to characterize cortical oscillations in the P8-10
prefrontal cortex. We also routinely use in utero electroporation
to express GFP or tdTomato in L2/3 precursors, but we did not
find in utero electroporation of GCaMP6s to be successful beyond
some scant expression at P7-9, suggesting to us that GCaMP6s
may in fact be toxic to neuronal precursors. Whether prenatal or
postnatal expression of a fluorescent indicator is ideal may, not
surprisingly, depend on the specific indicator and the cell type
being targeted.
Due to the technical challenges of performing such
experiments in young mice, there is a relative dearth of studies
that have recorded (or perturbed) brain network activity in vivo
during the first two postnatal weeks, compared with similar
studies in adults. Our P1 viral injection protocol is intended
to help fill this gap, and therefore has a wide range of potential
uses for neuroscientists, including those who are investigating
the causes of circuit dysfunction in a variety of developmental
brain disorders. Reasonable applications include the targeting of
specific cell types via the use of Cre-Lox genetics (e.g., injecting
AAVs encoding a Flexed constructs of GECIs or GEVIs into
Cre driver mice); manipulations of circuit function at early
postnatal ages via combination with optogenetic approaches,
or with chemogenetics with designer drugs exclusively activated
by designer receptors (DREADDs), as well as circuit mapping
studies with rabies virus tracing; to be combined with in vivo
recordings of neuronal activity in optically identified cells.
Our approach could also be used to enable simultaneous
in vivo imaging and behavioral assays in the same animals,
in order to elucidate how the maturation of cortical circuit
activity underlies the development of normal or aberrant
(disease-related) behaviors.
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